METHOHEXITAL SODIUM FOR INJECTION USP DIN 02571536
Health Canada record
| Active ingredient(s) | METHOHEXITAL SODIUM 500 MG |
|---|---|
| Dosage form | Powder For Solution |
| Route | Intravenous |
| Schedule | CONTROLLED DRUGS (CDSA IV) |
| Class | Human |
| ATC | N01AF01 METHOHEXITAL |
| Original market date | |
| Current status date | 14-Sep-2026 |
| Source | Health Canada DPD |
Establishment licence of the holder
Sterimax Inc — licence 100925, currently licensed, last inspection rating C (2024-05-13).
No Canadian shortage report is currently matched to this DIN.
Other Canadian products containing METHOHEXITAL SODIUM
| DIN | Product | Company | Form | Strength | Status |
|---|---|---|---|---|---|
| 00128678 | BRIETAL SODIUM AMPOULE 660 | ELI LILLY CANADA INC | Powder For Solution | METHOHEXITAL SODIUM 500 MG | Cancelled Post Market |
Notices of Compliance
| NOC | Date | Submission | Reason |
|---|---|---|---|
| 38285 | 2026-09-14 | New Drug Submission (NDS) |
Special Access Programme
This molecule appears on Health Canada's list of drugs most often requested through the Special Access Programme.
Request a quote for METHOHEXITAL SODIUM FOR INJECTION USP